PUBLISHED: Clinical, laboratory & molecular findings & long-term follow-up data in 96 French patients with PMM2-CDGhttps://t.co/ecZEUnkhA3 pic.twitter.com/7swzMgcj4h
— Amour Fund (@AmourFund) October 19, 2017
PUBLISHED: Clinical, laboratory & molecular findings & long-term follow-up data in 96 French patients with PMM2-CDGhttps://t.co/ecZEUnkhA3 pic.twitter.com/7swzMgcj4h
— Amour Fund (@AmourFund) October 19, 2017